Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Gurizzan · SciRah

Researcher profile · Semantic Scholar

C. Gurizzan

Share profile

C. Gurizzan — researcher profile on SciRah

h-index: 12
Works: 64
Citations: 488

Most-cited papers

Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis.
E. Roca, C. Gurizzan, V. Amoroso, W. Vermi +2 more
2017Cancer Treatment Reviews84 citations
Semantic Scholar
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy.
D. Smussi, D. Mattavelli, A. Paderno, C. Gurizzan +6 more
2023Cancer Treatment Reviews29 citations
Semantic Scholar
Immunotherapy for Nasopharyngeal Carcinoma: The Earlier the Better.
P. Bossi, C. Gurizzan, Anthony T. C. Chan
2023Journal of the American Medical Association (JAMA)29 citations
Semantic Scholar
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases
M. Laganà, C. Gurizzan, E. Roca, D. Cortinovis +20 more
2020Frontiers in Oncology27 citations Open access
Semantic Scholar
The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis.
A. Paderno, F. Petrelli, L. Lorini, Vincenzo Capriotti +2 more
2024Oral Oncology25 citations
Semantic Scholar
Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets
C. Romani, E. Bignotti, D. Mattavelli, A. Bozzola +22 more
2021Cancers25 citations Open access
Semantic Scholar
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy
R. Pedersini, P. di Mauro, S. Bosio, B. Zanini +12 more
2021Scientific Reports23 citations Open access
Semantic Scholar
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis.
C. Gurizzan, M. Zamparini, M. Volante, V. Tovazzi +6 more
2021Endocrine-Related Cancer22 citations
Semantic Scholar
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial.
P. Bossi, A. Alberti, C. Bergamini, C. Resteghini +15 more
2025European Journal of Cancer18 citations
Semantic Scholar
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.
David A. Lombardi, Michele Tomasoni, L. Lorini, C. Gurizzan +17 more
2022Oral Oncology17 citations
Semantic Scholar
Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial.
P. Bossi, A. Alberti, C. Bergamini, C. Resteghini +15 more
2022Journal of Clinical Oncology14 citations
Semantic Scholar
Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers
A. Esposito, Erika Stucchi, Maria Baronchelli, P. di Mauro +7 more
2022Journal of Clinical Medicine14 citations Open access
Semantic Scholar
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
M. Serafini, S. Cavalieri, L. Licitra, F. Pistore +18 more
2024Journal for ImmunoTherapy of Cancer12 citations Open access
Semantic Scholar
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports
E. Colombo, C. Gurizzan, A. Ottini, Francesca Caspani +8 more
2023Frontiers in Oncology12 citations Open access
Semantic Scholar
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
Elisabetta Roberti, M. Merlano, M. Ravanelli, A. Alberti +16 more
2023Oral Oncology12 citations
Semantic Scholar
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders
L. Lorini, Michele Tomasoni, C. Gurizzan, C. Magri +17 more
2022Frontiers in Oncology12 citations Open access
Semantic Scholar
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways
C. Romani, L. Lorini, A. Bozzola, E. Bignotti +13 more
2023Scientific Reports11 citations Open access
Semantic Scholar
The present and the future of benzydamine: expert opinion paper
P. Bossi, C. Gurizzan, O. Guntinas-Lichius, R. Hainăroșie +1 more
2023Frontiers in Oral Health10 citations Open access
Semantic Scholar
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders.
C. Gurizzan, A. Licata, L. Lorini, Cesare Piazza +13 more
2025Oral Oncology9 citations Open access
Semantic Scholar
864MO Role of geriatric assessment in tailoring treatment of locally advanced head and neck cancer: The ELDERLY study
P. Bossi, A. Esposito, S. Vecchio, P. Nicolai +14 more
2021Annals of Oncology9 citations Open access
Semantic Scholar
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study
T. Savarese, A. Abate, R. Basnet, L. Lorini +10 more
2022Scientific Reports8 citations Open access
Semantic Scholar
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy
F. Bozzetti, C. Gurizzan, S. Lal, A. Van Gossum +4 more
2021European Archives of Oto-Rhino-Laryngology8 citations Open access
Semantic Scholar
Treatment of primary tumor in metastatic head and neck Carcinoma: A systematic review and Meta-Analysis.
F. Petrelli, L. Lorini, A. Paderno, Daniela Carioli +6 more
2025Oral Oncology7 citations
Semantic Scholar
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR
I. Grossi, Claudia Assoni, L. Lorini, D. Smussi +9 more
2024Oncology Report7 citations Open access
Semantic Scholar
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial
C. Gurizzan, L. Lorini, A. Paderno, Michele Tomasoni +14 more
2021BMC Cancer7 citations Open access
Semantic Scholar
Oral potentially malignant disorders: new insights for future treatment.
C. Gurizzan, L. Lorini, P. Bossi
2020Current Opinion in Otolaryngology & Head and Neck Surgery6 citations
Semantic Scholar
Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group
D. Mattavelli, Gunnar Wichmann, D. Smussi, A. Paderno +17 more
2024Frontiers in Oncology5 citations Open access
Semantic Scholar
Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis
F. Petrelli, M. Nardone, F. Trevisan, D. Carioli +8 more
2022European Archives of Oto-Rhino-Laryngology5 citations
Semantic Scholar
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials
C. Gurizzan, M. Cinquini, L. Legramandi, C. Resteghini +7 more
2025Therapeutic Advances in Medical Oncology4 citations Open access
Semantic Scholar
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer.
L. Lorini, R. Gili, C. Resteghini, Riccardo Gerosa +5 more
2025Oral Oncology4 citations
Semantic Scholar
Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study.
C. Gurizzan, E. Roca, Andrea Faggiano, D. Paoli +7 more
2020Journal of Cardiovascular Medicine4 citations
Semantic Scholar
A prospective study with Comprehensive Geriatric Assessment (CGA) before curative treatment in older patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
M. C. Rocca, A. Esposito, S. Vecchio, P. Nicolai +16 more
2026Oral Oncology2 citations
Semantic Scholar
A phase II, open-label study to improve compliance and time of treatment after obtaining complete response (CR) through a tailored schedule of sonidegib in locally advanced basal cell carcinomas (LA BCC) – the SONIBEC trial
C. Resteghini, M. Variolo, Sara Farinatti, Andrea Alberti +15 more
2026EJC Skin Cancer2 citations Open access
Semantic Scholar
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era.
A. Alberti, C. Gurizzan, C. Resteghini, A. Trama +24 more
2025European Journal of Cancer2 citations Open access
Semantic Scholar
A phase II, open-label study to improve compliance and time of treatment after obtaining complete response (CR) through a tailored schedule of sonidegib in locally advanced basal cell carcinomas (laBCC): The SONIBEC trial.
C. Resteghini, Sara Farinatti, Andrea Alberti, V. Tovazzi +13 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Clinical Trials for Patients with Salivary Gland Cancers: A Systematic Review of Worldwide Registers and an Evaluation of Current Challenges.
P. Jiménez-Labaig, L. Lorini, C. Gurizzan, E. Kinloch +10 more
2025Critical reviews in oncology/hematology1 citations Open access
Semantic Scholar
856P Safety of neoadjuvant PARP inhibitor and immunotherapy in locally advanced HPV-negative head and neck squamous cell carcinoma (PRIME H&N Study)
L. Lorini, E. Stucchi, C. Gurizzan, C. Resteghini +15 more
2024Annals of Oncology1 citations Open access
Semantic Scholar
891P Pembrolizumab and olaparib in recurrent/metastatic, platinum resistant nasopharyngeal cancer: The POINT study
C. Gurizzan, S. Farinatti, A. Alberti, P. Bonomo +12 more
2024Annals of Oncology1 citations
Semantic Scholar
Where do we stand with immunotherapy for nonmelanoma skin cancers in the curative setting?
Andrea Alberti, C. Gurizzan, A. Baggi, P. Bossi
2023Current Opinion in Otolaryngology & Head and Neck Surgery1 citations
Semantic Scholar
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic
C. Gurizzan, R. Pedersini, Carla Fornaro, C. Sardini +16 more
2021Frontiers in Oncology1 citations Open access
Semantic Scholar
CtDNA as a biomarker in Salivary Gland Cancer (SAGACE trial)
F. Riva, F. Gaino, Erika Stucchi, C. Gurizzan +11 more
2026Radiotherapy and Oncology0 citations
Semantic Scholar
Carcinoma of unknown primary (CUP) of the head and neck: state of the art and future perspectives
Sara Farinatti, A. Paderno, C. Giannitto, C. Gurizzan +10 more
2026Frontiers in Oncology0 citations Open access
Semantic Scholar
Curative approaches for adenoid cystic carcinoma: a multifaceted disease.
L. Lorini, M. Tomasoni, M. S. Iqbal, V. Salvestrini +8 more
2026Oral Oncology0 citations
Semantic Scholar
Abstract 2866: Host-microbe-epigenetic crosstalk: Dissecting the role of microbiome, immune dysregulation, and DNA methylation in squamous cell carcinoma
A. Licata, C. Gurizzan, Deborah Lenoci, Marta Lucchetta +5 more
2026Cancer Research0 citations
Semantic Scholar
Activity of cytotoxic chemotherapy in recurrent and/or metastatic salivary glands: a multicenter retrospective study
L. Lorini, S. Farinatti, Ilaria Mascagni, Federica Avanzi +17 more
2026Radiotherapy and Oncology0 citations
Semantic Scholar
Single cell analysis of recurrent/metastatic, platinum resistant nasopharyngeal cancer patients treated within the POINT trial: Transitional insights for future research.
C. Gurizzan, Chiara Laura, S. Farinatti, F. Riva +13 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Prediction of loss of heterozygosity in oral cavity dysplasia through vascular pattern
F. Tartaglia, Giovanna Rossi, Luca T. Mainardi, Haiyang Wang +6 more
2026Frontiers in Oral Health0 citations Open access
Semantic Scholar
1392P The impede phase II trial: Avelumab (A) in high-risk oral potentially malignant disorders (OPMDs) for prevention of malignant transformation
E. Stucchi, C. Romani, L. Lorini, S. Koljenović +16 more
2025Annals of Oncology0 citations Open access
Semantic Scholar
1338P Neoadjuvant PARP inhibitor and immunotherapy in locally advanced HPV-negative head and neck squamous cell carcinoma (PRIME H&N Study)
L. Lorini, E. Stucchi, D. Mattavelli, M. Iuzzolino +16 more
2025Annals of Oncology0 citations Open access
Semantic Scholar
1379P Genome wide copy number alterations in ctDNA as novel biomarker in head and neck squamous cell cancer (IDENTIFY Trial)
F. Gaino, E. Stucchi, C. Gurizzan, F. Riva +16 more
2025Annals of Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Lorini×31
Invite
L. Lorini — researcher profile on SciRah
C. Resteghini×22
Invite
C. Resteghini — researcher profile on SciRah
P. Bossi×17
Invite
P. Bossi — researcher profile on SciRah
A. Paderno×16
Invite
A. Paderno — researcher profile on SciRah

×9

Invite

A. Berruti — researcher profile on SciRah

Invite

P. Bossi — researcher profile on SciRah

D. Mattavelli×8

Invite

D. Mattavelli — researcher profile on SciRah

M. Ravanelli×8

Invite

M. Ravanelli — researcher profile on SciRah

Invite

L. Lorini — researcher profile on SciRah

Invite

P. Bossi — researcher profile on SciRah

Invite

A. Bozzola — researcher profile on SciRah

M. Zamparini×7

Invite

M. Zamparini — researcher profile on SciRah